Kezar Life Sciences Inc Stock

$7.47

0.40% yesterday

Nasdaq, Nov 25, 10:00 pm CET

ISIN

US49372L1008

Symbol

KZR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Kezar Life Sciences Inc Stock price

$7.47

-20.63 73.42% 5Y

Nasdaq, Closing price Mon, Nov 25 2024

-0.03 0.40%

ISIN

US49372L1008

Symbol

KZR

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Key metrics

Market capitalization	$54.50m
Enterprise Value	$-76.98m
P/E (TTM) P/E ratio	negative
EV/FCF (TTM) EV/FCF	1.01
P/B ratio (TTM) P/B ratio	0.41
Revenue growth (TTM) Revenue growth	-100.00%
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-95.96m
Free Cash Flow (TTM) Free Cash Flow	$-76.39m
Cash position	$148.39m
EPS (TTM) EPS	$-13.15
P/E forward	negative
P/S forward	22.71
EV/Sales forward	negative
Short interest	2.50%

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Get Started for Free Today

Kezar Life Sciences Inc Stock Analysis

Unlock Scores for Free

??

6 Analysts have issued a Kezar Life Sciences Inc forecast:

2x Buy

33%

4x Hold

67%

More details on Analyst Estimates Including Price Targets

6 Analysts have issued a Kezar Life Sciences Inc forecast:

Buy

33%

Hold

67%

Analyst Estimates with Stock Price Targets

Financial data from Kezar Life Sciences Inc

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Sep '24		+/- %
Revenue	- -	- 100%
- Direct Costs	1.06 1.06	34% 34% -
Gross Profit	-1.06 -1.06	115% 115% -
- Selling and Administrative Expenses	21 21	15% 15% -
- Research and Development Expense	72 72	7% 7% -
EBITDA	-95 -95	2% 2% -
- Depreciation and Amortization	1.06 1.06	- -
EBIT (Operating Income) EBIT	-96 -96	1% 1% -
Net Profit	-96 -96	9% 9% -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Kezar Life Sciences Inc Stock News

Neutral

Business Wire

●

14 days ago

Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today reported financial results for the third quarter ended September 30, 2024, and provided a business update. “The team at Kezar has made great progress towards completing t...

Neutral

Business Wire

●

21 days ago

Glancy Prongay & Murray LLP Announces Investigation of Kezar Life Sciences, Inc. (KZR)

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Kezar Life Sciences, Inc. (Nasdaq: KZR) concerning the Company and its directors' and officers' possible violations of state laws. If you own Kezar Life Sciences stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respe...

Neutral

Business Wire

●

29 days ago

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of one-for-ten (the “Reverse Stock Split”). The Reverse Stock Sp...

More Kezar Life Sciences Inc News

Company Profile

Kezar Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco, California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Head office	United States
CEO	Christopher Kirk
Employees	58
Founded	2015
Website	www.kezarlifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now